Dolby Laboratories vs Kilroy Realty
DLB and KRC side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How DLB and KRC compare
Dolby Laboratories is the larger company, worth 1.5 times as much as Kilroy Realty ($6.1B against $4.2B).
On earnings, Dolby Laboratories is cheaper: it trades at 27.5× trailing earnings, against 149× for Kilroy Realty.
Dolby Laboratories grew revenue faster over the last twelve months (0.55% versus −3.6% for Kilroy Realty).
Both pay dividends: Dolby Laboratories yields 2.2% and Kilroy Realty 6.0%.
Dolby Laboratories scores higher on the StockData Score (18 against 7 for Kilroy Realty), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | DLB | KRC |
|---|---|---|
| Size and price | ||
| Market cap | $6.1B | $4.2B |
| Share price | $64.59 | $35.82 |
| Change, 1 year | −1.8% | −15.2% |
| Change, 5 years | −27.9% | −48.5% |
| Beta (5Y) | 0.75 | 1.02 |
| Employees | 2,051 | 241 |
| StockData Score | ||
| Total score | 18 (better) | 7 |
| Valuation score | 2 | 3 (better) |
| Growth score | 2 (better) | 1 |
| Performance score | 4 (better) | 0 |
| Health score | 6 (better) | 0 |
| Dividend score | 4 (better) | 3 |
| Valuation | ||
| P/E | 27.5× (better) | 149× |
| P/S | 4.5× | 3.8× (better) |
| P/B | 2.3× | 0.8× (better) |
| EV/EBITDA | 16.2× | – |
| P/FCF | 15.4× | – |
| PEG | 2.09 (better) | 26.64 |
| FCF yield | 6.5% | – |
| Fair value | $60.87 | $47.15 |
| Margin of safety | −6.1% | 24.0% (better) |
| Growth | ||
| Revenue growth (TTM) | 0.55% (better) | −3.6% |
| Revenue growth, 5Y average | 3.0% | 4.4% (better) |
| Net income growth (TTM) | −14.4% | – |
| EPS growth (TTM) | −13.6% (better) | −91.1% |
| EPS growth, 5Y average | 3.1% | 7.3% (better) |
| Profitability | ||
| Gross margin | 87.6% | – |
| Operating margin | 17.7% | – |
| Net margin | 16.7% | – |
| FCF margin | 29.0% | – |
| Return on equity | 8.7% | – |
| Return on invested capital | 10.5% | – |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Current ratio | 3.19 | – |
| Altman Z-score | 8.62 (better) | 0.60 |
| Piotroski F-score | 6 | – |
| Dividends and buybacks | ||
| Dividend yield | 2.2% | 6.0% (better) |
| Payout ratio | 59.4% | – |
| Years of dividend growth | 4 (better) | 0 |
| Dividend growth, 5Y average | 8.4% (better) | 1.9% |
| Buyback yield | 3.9% | – |
| Shareholder yield | 6.1% (better) | 6.0% |
| Ownership | ||
| Held by institutions | 66.1% | 117% |
| Held by insiders | 37.9% | 1.1% |
| Insider net buying, 12 months | −$11.4M | −$3.1M (better) |
| Superinvestors holding | – | 2 |
| Short interest, % of float | 10.3% | 11.7% |
Go deeper
- DLB stock overview
- DLB income statement
- DLB valuation and score
- KRC stock overview
- KRC income statement
- KRC valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.